News & Events

2016, Press Releases, Scientific

The European Commission (EC) has granted Orphan Drug Designation to L19TNF

Oct 28, 2016

Philogen S.p.A. announced that the European Commission (EC) has granted Orphan Drug Designation to L19TNF for the treatment of soft-tissue sarcoma.

PHILOGEN S.P.A. RECEIVES ORPHAN DRUG DESIGNATION FOR THE TREATMENT OF SOFT-TISSUE SARCOMA

Last News & Events

Jun 2025 10

Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus royalties.

May 2025 29

The MedChem division of the Italian Chemical Society (SCI) awarded two Prizes to Philochem employees: Samuele Cazzamalli (Head of Chemistry) and Sara Puglioli (Research Scientist)

« Previous
1
2
3
4
…
132
Next »